Literature DB >> 11489963

Cutting edge: predominant expression of a novel Ikaros isoform in normal human hemopoiesis.

K J Payne1, J H Nicolas, J Y Zhu, L W Barsky, G M Crooks.   

Abstract

Murine studies implicate Ikaros proteins as regulators of hemopoiesis, particularly in the lymphoid lineages. High homology between murine and human Ikaros suggests that Ikaros expression in the two might be similar. However, initial human studies that focused on leukemia detected novel Ikaros transcripts in patient samples. Thus, novel Ikaros splice forms and DNA nonbinding isoforms were linked with malignancy. We undertook an extensive analysis of normal human Ikaros expression to determine whether novel mRNAs are expressed as proteins and the extent to which these splice variants are unique to leukemia. Here we show that both mRNA and protein for DNA nonbinding Ikaros isoforms and splice variants previously linked to leukemia are expressed in normal human cells. However, our studies identify a new Ikaros isoform not previously described in mouse or human. This isoform is the predominant Ikaros protein in normal human cells, but not in leukemia cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489963     DOI: 10.4049/jimmunol.167.4.1867

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Ikaros limits basophil development by suppressing C/EBP-α expression.

Authors:  Kavitha N Rao; Craig Smuda; Gregory D Gregory; Booki Min; Melissa A Brown
Journal:  Blood       Date:  2013-08-29       Impact factor: 22.113

2.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

3.  Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.

Authors:  J M Boer; A van der Veer; D Rizopoulos; M Fiocco; E Sonneveld; H A de Groot-Kruseman; R P Kuiper; P Hoogerbrugge; M Horstmann; M Zaliova; C Palmi; J Trka; E Fronkova; M Emerenciano; M do Socorro Pombo-de-Oliveira; W Mlynarski; T Szczepanski; K Nebral; A Attarbaschi; N Venn; R Sutton; C J Schwab; A Enshaei; A Vora; M Stanulla; M Schrappe; G Cazzaniga; V Conter; M Zimmermann; A V Moorman; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

4.  Regulator of myeloid differentiation and function: The secret life of Ikaros.

Authors:  Olivia L Francis; Jonathon L Payne; Rui-Jun Su; Kimberly J Payne
Journal:  World J Biol Chem       Date:  2011-06-26

5.  Ikaros isoforms: The saga continues.

Authors:  Zhanjun Li; Laura A Perez-Casellas; Aleksandar Savic; Chunhua Song; Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

6.  Cell cycle-specific function of Ikaros in human leukemia.

Authors:  Zhanjun Li; Chunhua Song; Hongsheng Ouyang; Liangxue Lai; Kimberly J Payne; Sinisa Dovat
Journal:  Pediatr Blood Cancer       Date:  2011-11-21       Impact factor: 3.167

7.  Ikaros: master of hematopoiesis, agent of leukemia.

Authors:  Kara L Davis
Journal:  Ther Adv Hematol       Date:  2011-12

8.  Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis.

Authors:  Nadine Nelson; Shengyan Xiang; Xiaohong Zhang; Danielle Gilvary; Julie Djeu; Kazim Husain; Mokenge Malafa; Nasreen Vohra; Shari Pilon-Thomas; Tomar Ghansah
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

9.  A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.

Authors:  Daria Capece; Francesca Zazzeroni; Maria Michela Mancarelli; Daniela Verzella; Mariafausta Fischietti; Ambra Di Tommaso; Rita Maccarone; Sara Plebani; Mauro Di Ianni; Alberto Gulino; Edoardo Alesse
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Alternative Splice Variants Modulates Dominant-Negative Function of Helios in T-Cell Leukemia.

Authors:  Shaorong Zhao; Wei Liu; Yinghui Li; Pengjiang Liu; Shufang Li; Daolei Dou; Yue Wang; Rongcun Yang; Rong Xiang; Feifei Liu
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.